Once the concentration of 2-ME2 exceeded 0.5 μM, downregulated C-myc gene expression could exert roles in anti-CML cell proliferation and inducing apoptosis. The gene discussed is MYC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.